Form 4 for RMD ResMed|
Accepted 2025-11-13 00:00:00 ET · period of report 2025-11-11 · accession 0000943819-25-000117 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-13 | 2025-11-11 | RMD | FARRELL PETER C | Dir | F - Tax | $250.10 | -162.95 | 68.1K | -0.2% | -$40.8K | |
| 2025-11-13 | 2025-11-12 | RMD | FARRELL PETER C | Dir | S - Sale | $252.05 | -2,000 | 66.1K | -3% | -$504.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | ResMed Common Stock | 2025-11-11 | F | D | 162.95 | $250.10 | 68,110 | D | — | — | |
| 2 | Common | ResMed Common Stock | 2025-11-12 | S | D | 2,000 | $252.05 | 66,110 | D | — | — |